- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06730698
Thumb Muscle Thickness and Strength in CMC Osteoarthritis
March 22, 2025 updated by: Busra Sirin, Beylikduzu State Hospital
Ultrasonographic Measurement of Thumb Muscle Thickness and Evaluation of Pinch and Grip Strength in First Carpometacarpal Joint Osteoarthritis: A Comparison of Early and Advanced Stages
A total of 34 patients aged between 50-80 years, diagnosed with first carpometacarpal joint osteoarthritis based on hand radiographs taken within the last 3 months, will be included in the study from the Physical Therapy and Rehabilitation outpatient clinic.
Sociodemographic data such as age, gender, height, weight, and BMI will be recorded.
Based on their current radiographs, patients will be classified into two groups according to the Eaton-Littler classification: Stage 1-2 (early stage) and Stage 3-4 (advanced stage).
Pain levels will be assessed using the Visual Analog Scale (VAS).
Hand grip strength will be evaluated with a Jamar hand dynamometer, and pinch grip strength will be assessed with a Jamar pinch meter.
The thicknesses of the abductor pollicis brevis, first dorsal interosseous, and opponens pollicis muscles will be measured using ultrasound.
All assessments will be performed separately for the dominant and non-dominant hands.
Study Overview
Study Type
Observational
Enrollment (Actual)
34
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beylikdüzü
-
Istanbul, Beylikdüzü, Turkey, 34147
- Beylikduzu State Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Probability Sample
Study Population
The study population includes patients aged 50-80 years with first carpometacarpal joint osteoarthritis, classified into early and advanced stages based on radiographs, excluding those with confounding medical or cognitive conditions.
Description
Inclusion Criteria:
- Patients aged 50-80 years.
- Diagnosed with first carpometacarpal joint osteoarthritis.
- Presence of a hand radiograph taken within the last 3 months.
- Volunteered to participate in the study.
Exclusion Criteria:
- Refusal to participate in the study.
- Use of medications that may suppress osteoarthritis flares.
- Presence of rheumatologic diseases causing peripheral joint involvement.
- History of fractures or surgeries involving the first carpometacarpal joint.
- Presence of psychiatric disorders.
- Presence of cognitive impairments that could hinder understanding or performance of study-related tasks.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Early stage osteoarthritis
Early stage osteoarthritis according to Eaton-Litter classification (stage 1 and 2)
|
No intervention
|
|
Advanced stage osteoarthritis
Advanced stage osteoarthritis according to Eaton-Litter classification (stage 3 and 4)
|
No intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Thumb Muscle Thickness (Ultrasound)
Time Frame: 0 day
|
Measurement of the thickness of three thumb muscles-abductor pollicis brevis, first dorsal interosseous, and opponens pollicis-using ultrasonography.
These measurements will help determine muscle atrophy or hypertrophy related to disease severity and stage
|
0 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Grip Strength
Time Frame: 0 day
|
Assessed using a Jamar hand dynamometer.
This measure evaluates overall hand strength, which is often impaired in advanced stages of carpometacarpal joint osteoarthritis.
|
0 day
|
|
Pinch Strength
Time Frame: 0 day
|
Assessed using a Jamar pinch meter.
This measure evaluates the strength of the thumb-index finger pinch, a critical function for fine motor activities.
It is particularly relevant to functional limitations seen in osteoarthritis.
|
0 day
|
|
Pain Level (VAS)
Time Frame: 0 day
|
Pain intensity will be measured using the Visual Analog Scale (VAS).
Patients will mark their perceived pain level on a 10 cm scale, providing a quantitative measure of pain severity in both early and advanced stages.
|
0 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Büşra Şirin Ahısha, Beylikduzu State Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 10, 2024
Primary Completion (Actual)
January 20, 2025
Study Completion (Actual)
January 20, 2025
Study Registration Dates
First Submitted
December 9, 2024
First Submitted That Met QC Criteria
December 9, 2024
First Posted (Actual)
December 12, 2024
Study Record Updates
Last Update Posted (Actual)
March 26, 2025
Last Update Submitted That Met QC Criteria
March 22, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BeylikduzuStateH11
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.